Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00580775 · ClinicalTrials.gov registry record
Study of Early Hormone Replacement Therapy on Risk Factors for Sudden Cardiac Death
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 25
- Enrollment target
NCT00580775 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 25 participants.
The verdict
NCT00580775 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
As an ancillary study to the KEEPS study (see ClinicalTrials.gov Identifier: NCT00154180), the primary purpose is to measure effects of estrogen vs. placebo in menopausal women, on autonomic function and repolarization; both measured non-invasively via holter monitoring.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2005-09 |
| Est. Completion | 2010-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00580775
The ClinicalTrials.gov registry entry for NCT00580775 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00580775 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00580775 about?
NCT00580775 is a clinical study titled "Study of Early Hormone Replacement Therapy on Risk Factors for Sudden Cardiac Death". As an ancillary study to the KEEPS study (see ClinicalTrials.gov Identifier: NCT00154180), the primary purpose is to measure effects of estrogen vs. placebo in menopausal women, on autonomic function and repolarization; both measured non-invasively via holter monitoring.
What is the current status of trial NCT00580775?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2005-09. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT00580775?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.